Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Neurosci ; 22(2): 191-204, 2019 02.
Article in English | MEDLINE | ID: mdl-30617257

ABSTRACT

Coding variants in the triggering receptor expressed on myeloid cells 2 (TREM2) are associated with late-onset Alzheimer's disease (AD). We demonstrate that amyloid plaque seeding is increased in the absence of functional Trem2. Increased seeding is accompanied by decreased microglial clustering around newly seeded plaques and reduced plaque-associated apolipoprotein E (ApoE). Reduced ApoE deposition in plaques is also observed in brains of AD patients carrying TREM2 coding variants. Proteomic analyses and microglia depletion experiments revealed microglia as one origin of plaque-associated ApoE. Longitudinal amyloid small animal positron emission tomography demonstrates accelerated amyloidogenesis in Trem2 loss-of-function mutants at early stages, which progressed at a lower rate with aging. These findings suggest that in the absence of functional Trem2, early amyloidogenesis is accelerated due to reduced phagocytic clearance of amyloid seeds despite reduced plaque-associated ApoE.


Subject(s)
Alzheimer Disease/genetics , Amyloid/metabolism , Apolipoproteins E/metabolism , Brain/pathology , Membrane Glycoproteins/genetics , Plaque, Amyloid/genetics , Receptors, Immunologic/genetics , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Amyloid beta-Peptides/genetics , Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/genetics , Amyloid beta-Protein Precursor/metabolism , Animals , Brain/metabolism , Disease Models, Animal , Genotype , Humans , Membrane Glycoproteins/metabolism , Mice , Mice, Transgenic , Microglia/metabolism , Microglia/pathology , Phagocytosis/physiology , Plaque, Amyloid/metabolism , Plaque, Amyloid/pathology , Receptors, Immunologic/metabolism
2.
J Exp Med ; 212(11): 1803-9, 2015 Oct 19.
Article in English | MEDLINE | ID: mdl-26458770

ABSTRACT

Immune cells of myeloid lineage are encountered in the Alzheimer's disease (AD) brain, where they cluster around amyloid-ß plaques. However, assigning functional roles to myeloid cell subtypes has been problematic, and the potential for peripheral myeloid cells to alleviate AD pathology remains unclear. Therefore, we asked whether replacement of brain-resident myeloid cells with peripheral monocytes alters amyloid deposition in two mouse models of cerebral ß-amyloidosis (APP23 and APPPS1). Interestingly, early after repopulation, infiltrating monocytes neither clustered around plaques nor showed Trem2 expression. However, with increasing time in the brain, infiltrating monocytes became plaque associated and also Trem2 positive. Strikingly, however, monocyte repopulation for up to 6 mo did not modify amyloid load in either model, independent of the stage of pathology at the time of repopulation. Our results argue against a long-term role of peripheral monocytes that is sufficiently distinct from microglial function to modify cerebral ß-amyloidosis. Therefore, myeloid replacement by itself is not likely to be effective as a therapeutic approach for AD.


Subject(s)
Alzheimer Disease/therapy , Amyloid beta-Peptides/metabolism , Brain/metabolism , Myeloid Cells/physiology , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Animals , Brain/pathology , Disease Models, Animal , Female , Male , Membrane Glycoproteins/analysis , Mice , Mice, Inbred C57BL , Monocytes/physiology , Receptors, Immunologic/analysis
3.
PLoS One ; 10(5): e0125418, 2015.
Article in English | MEDLINE | ID: mdl-26017149

ABSTRACT

Alzheimer´s disease (AD) is the most common neurodegenerative disorder. AD neuropathology is characterized by intracellular neurofibrillary tangles and extracellular ß-amyloid deposits in the brain. To elucidate the complexity of AD pathogenesis a variety of transgenic mouse models have been generated. An ideal imaging system for monitoring ß-amyloid plaque deposition in the brain of these animals should allow 3D-reconstructions of ß-amyloid plaques via a single scan of an uncropped brain. Ultramicroscopy makes this possible by replacing mechanical slicing in standard histology by optical sectioning. It allows a time efficient analysis of the amyloid plaque distribution in the entire mouse brain with 3D cellular resolution. We herein labeled ß-amyloid deposits in a transgenic mouse model of cerebral ß-amyloidosis (APPPS1 transgenic mice) with two intraperitoneal injections of the amyloid-binding fluorescent dye methoxy-X04. Upon postmortem analysis the total number of ß-amyloid plaques, the ß-amyloid load (volume percent) and the amyloid plaque size distributions were measured in the frontal cortex of two age groups (2.5 versus 7-8.5 month old mice). Applying ultramicroscopy we found in a proof-of-principle study that the number of ß-amyloid plaques increases with age. In our experiments we further observed an increase of large plaques in the older age group of mice. We demonstrate that ultramicroscopy is a fast, and accurate analysis technique for studying ß-amyloid lesions in transgenic mice allowing the 3D staging of ß-amyloid plaque development. This in turn is the basis to study neural network degeneration upon cerebral ß-amyloidosis and to assess Aß-targeting therapeutics.


Subject(s)
Amyloidosis/pathology , Brain/pathology , Microscopy/methods , Plaque, Amyloid/pathology , Alkenes/analysis , Alkenes/metabolism , Amyloid beta-Protein Precursor/genetics , Animals , Benzene Derivatives/analysis , Benzene Derivatives/metabolism , Disease Models, Animal , Fluorescent Dyes/analysis , Fluorescent Dyes/metabolism , Humans , Imaging, Three-Dimensional/methods , Mice, Inbred C57BL , Mice, Transgenic , Stilbenes
4.
Biotechniques ; 55(2): 75-8, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23931595

ABSTRACT

Osmotic minipumps represent a convenient and established method for targeted delivery of agents into the brain of small rodents. Agents unable to cross the blood brain barrier can be directly infused into the brain parenchyma or lateral ventricle through implanted cannulas. The small volume of the minipump reservoir typically limits the infusion time to 4-6 weeks. Pump changes with reattachment of a new pump reservoir to the cannula might lead to brain tissue irritation or increased intracranial pressure associated with hydrocephalus. Here, we describe a pump reservoir exchange technique using a Y-shaped connection piece (Y-con) between the infusion cannula and the pump reservoir. This allows repeated replacement of a subcutaneously installed pump reservoir for brain delivery of agents in mice. Experimental evaluation of Y-con pump replacement revealed no signs of tissue irritation or hydrocephalus and allowed extended controlled delivery of infusion agents in the brain.


Subject(s)
Brain/metabolism , Drug Delivery Systems/instrumentation , Infusion Pumps, Implantable , Animals , Drug Delivery Systems/adverse effects , Infusions, Intraventricular , Male , Mice , Mice, Transgenic , Osmosis , Time Factors
6.
Proc Natl Acad Sci U S A ; 109(44): 18150-5, 2012 Oct 30.
Article in English | MEDLINE | ID: mdl-23071306

ABSTRACT

Under most physiological circumstances, monocytes are excluded from parenchymal CNS tissues. When widespread monocyte entry occurs, their numbers decrease shortly after engraftment in the presence of microglia. However, some disease processes lead to focal and selective loss, or dysfunction, of microglia, and microglial senescence typifies the aged brain. In this regard, the long-term engraftment of monocytes in the microglia-depleted brain remains unknown. Here, we report a model in which a niche for myeloid cells was created through microglia depletion. We show that microglia-depleted brain regions of CD11b-HSVTK transgenic mice are repopulated with new Iba-1-positive cells within 2 wk. The engrafted cells expressed high levels of CD45 and CCR2 and appeared in a wave-like pattern frequently associated with blood vessels, suggesting the engrafted cells were peripheral monocytes. Although two times more numerous and morphologically distinct from resident microglia up to 27 wk after initial engraftment, the overall distribution of the engrafted cells was remarkably similar to that of microglia. Two-photon in vivo imaging revealed that the engrafted myeloid cells extended their processes toward an ATP source and displayed intracellular calcium transients. Moreover, the engrafted cells migrated toward areas of kainic acid-induced neuronal death. These data provide evidence that circulating monocytes have the potential to occupy the adult CNS myeloid niche normally inhabited by microglia and identify a strong homeostatic drive to maintain the myeloid component in the mature brain.


Subject(s)
Central Nervous System/cytology , Homeostasis , Microglia/cytology , Adenosine Triphosphate/metabolism , Animals , Central Nervous System/metabolism , Mice , Microglia/metabolism , Thymidine Kinase/genetics
7.
Neuro Oncol ; 14(4): 471-81, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22298526

ABSTRACT

Intracerebral experimental gliomas attract intravenously injected murine or human bone marrow-derived hematopoietic progenitor and stem cells (HPC) in vitro, ex vivo, and in vivo, indicating that these progenitor cells might be suitable vehicles for a cell-based delivery of therapeutic molecules to malignant gliomas. With regard to therapeutic application, it is important to investigate cell fates in vivo (i.e., the time-dependent intratumoral and systemic distribution after intravenously injection). Conventional histological analysis has limitations in this regard because longitudinal monitoring is precluded. Here, we used 2-photon laser scanning microscopy (2PLSM), positron emission tomography (PET), and MRI to study the fate of intravenously injected HPC carrying fluorescence, bioluminescence, and PET reporter genes in glioma-bearing mice. Our 2PLSM-based monitoring studies revealed that HPC homing to intracerebral experimental gliomas occurred already within the first 6 h and was most efficient within the first 24 h after intravenous injection. The highest PET signals were detected in intracerebral gliomas, whereas the tracer uptake in other organs, notably spleen, lung, liver, and muscle, remained at background levels. The results have important implications for designing schedules for therapeutic cell-based anti-glioma approaches. Moreover, the PET reporter-based imaging technique will allow noninvasive monitoring of cell fate in future cell-based therapeutic antiglioma approaches.


Subject(s)
Cell Movement , Cell- and Tissue-Based Therapy , Glioma/pathology , Hematopoietic Stem Cells/physiology , Microscopy, Confocal/methods , Animals , Cell Line, Tumor , Humans , Magnetic Resonance Imaging , Mice , Positron-Emission Tomography
8.
J Neurosci Methods ; 205(2): 357-63, 2012 Apr 15.
Article in English | MEDLINE | ID: mdl-22093765

ABSTRACT

Repetitive in vivo imaging in mice has become an indispensable tool for studying dynamic changes in structure and function of the brain. We describe a head fixation system, which allows rapid re-localization of previously imaged regions of interest (ROIs) within the brain. Such ROIs can be automatically relocated and imaged over weeks to months with negligible rotational change and only minor translational errors. Previously stored imaging positions can be fully automated re-localized within a few seconds. This automated rapid and accurate relocation simplifies image acquisition and post-processing in longitudinal imaging experiments. Moreover, as the laser is only used for data acquisition and not for finding previously imaged ROIs, the risk of laser induced tissue damage and photobleaching is greatly reduced. Thus, here described head fixation device appears well suited for in vivo repetitive long-term imaging in rodent brain.


Subject(s)
Microscopy/instrumentation , Neuroimaging/instrumentation , Restraint, Physical/instrumentation , Animals , Brain/anatomy & histology , Brain/physiology , Mice , Photons , Time Factors
9.
Nat Neurosci ; 12(11): 1361-3, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19838177

ABSTRACT

In Alzheimer's disease, microglia cluster around beta-amyloid deposits, suggesting that these cells are important for amyloid plaque formation, maintenance and/or clearance. We crossed two distinct APP transgenic mouse strains with CD11b-HSVTK mice, in which nearly complete ablation of microglia was achieved for up to 4 weeks after ganciclovir application. Neither amyloid plaque formation and maintenance nor amyloid-associated neuritic dystrophy depended on the presence of microglia.


Subject(s)
Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Amyloid beta-Peptides/metabolism , CD11b Antigen/genetics , Microglia/physiology , Plague/pathology , Alzheimer Disease/genetics , Amyloid beta-Protein Precursor/genetics , Animals , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/metabolism , Antiviral Agents/adverse effects , Antiviral Agents/pharmacology , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay/methods , Female , Ganciclovir/adverse effects , Ganciclovir/pharmacology , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Green Fluorescent Proteins/genetics , Humans , Injections, Intra-Articular/methods , Male , Mice , Mice, Transgenic , Microglia/drug effects , Microscopy, Immunoelectron/methods , Mutation , Neuroaxonal Dystrophies/etiology , Neuroaxonal Dystrophies/metabolism , Neuroaxonal Dystrophies/pathology , Presenilin-1/genetics , Thymidine Kinase/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...